A high throughput assay to identify small molecule modulators of prostatic acid phosphatase

Current Chemical Genomics

Volumn 3, Issue 1, 2009, Pages 42-49

  Larsen, Rylan S ^a   Zylka, Mark J ^a   Scott, John E ^b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PHOSPHATASE PROSTATE ISOENZYME; ANTINOCICEPTIVE AGENT; BAS 00669251; BAS 02830262; BAS 03013122; BAS 07119722; BAS 08862870; BAS 08863852; BAS 08865249; DIFLUORO 4 METHYLUMBELLIFERYL PHOSPHATE; DIMETHYL SULFOXIDE; ENZYME INHIBITOR; FLUORESCENT DYE; TARTARIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CHRONIC PAIN; CONCENTRATION RESPONSE; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ASSAY; ENZYME INHIBITION; FLUORESCENCE; HIGH THROUGHPUT SCREENING; HUMAN; IC 50; MOLECULAR LIBRARY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VALIDATION PROCESS;

EID: 77953388445     PISSN: None     EISSN: 18753973     Source Type: Journal    
DOI: 10.2174/1875397300903010042     Document Type: Article

References (15)

1. Sowa NA, Vadakkan KI, Zylka MJ. Recombinant mouse PAP has pH-dependent ectonucleotidase activity and acts through A(1)-adenosine receptors to mediate antinociception. PLoS ONE 2009; 4: e42-8.
2. Zylka MJ, Sowa NA, Taylor-Blake B, et al. Prostatic acid phosphatase is an ectonucleotidase and suppresses pain by generating adenosine. Neuron 2008; 60: 111-122
3. Kaija H, Patrikainen LOT, Alatalo SL, Vaananen HK, Vihko PT. Acid Phosphatases. In: Seibel MJ, Robins SP, Bilezikian JP, Eds. Dynamics of Bone and Cartilage Metabolism. London: Academic press 2006; pp. 165-180.
4. Beers SA, Schwender CF, Loughney DA, Malloy E, Demarest K, Jordan J. Phosphatase inhibitors - III. Benzylaminophosphonic acids as potent inhibitors of human prostatic acid phosphatase. Bioorg Med Chem 1996; 4: 1693-1701
5. Schwender CF, Beers SA, Malloy E, et al. Benzylphosphonic acid inhibitors of human prostatic acid phosphatase. Bioorg Med Chem Lett 1996; 6: 311-314 (Pubitemid 26056370)
6. Poderoso C, Maciel FC, Gorostizaga A, Bey P, Paz C, Podesta EJ. The obligatory action of protein tyrosine phosphatases in ACTH-stimulated steroidogenesis is exerted at the level of StAR protein. Endocr Res 2002; 28: 413-417 (Pubitemid 36042494)
7. Ogata Y, Nakao S, Shimizu E, et al. Tyrosine phosphorylation is involved in Ca(2+)entry in human gingival fibroblasts. Cell Biol Int 2003; 27: 689-693
8. Parfenova H, Balabanova L, Leffler CW. Posttranslational regulation of cyclooxygenase by tyrosine phosphorylation in cerebral endothelial cells. Am J Physiol 1998; 274: C72-81. (Pubitemid 28099345)
9. Jakob CG, Lewinski K, Kuciel R, Ostrowski W, Lebioda L. Crystal structure of human prostatic acid phosphatase. Prostate 2000; 42: 211-218 (Pubitemid 30080420)
10. Ortlund E, LaCount MW, Lebioda L. Crystal structures of human prostatic acid phosphatase in complex with a phosphate ion and alpha- benzylaminobenzylphosphonic acid update the mechanistic picture and offer new insights into inhibitor design. Biochem 2003; 42: 383-389 (Pubitemid 36105756)
11. Schneider G, Lindqvist Y, Vihko P. Three-dimensional structure of rat acid phosphatase. EMBO J 1993; 12: 2609-2615 (Pubitemid 23218309)
12. Gee KR, Sun WC, Bhalgat MK, et al. Fluorogenic substrates based on fluorinated umbelliferones for continuous assays of phosphatases and β-galactosidases. Anal Biochem 1999; 273: 41-48
13. Zhang J, Thomas D, Chung Y, Oldenburg KR. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999; 4: 67-74. (Pubitemid 29278954)
14. LaCount MW, Handy G, Lebioda L. Structural origins of L(+)-tartrate inhibition of human prostatic acid phosphatase. J Biol Chem 1998; 273: 30406-30409 (Pubitemid 28545512)
15. Pulgarin JAM, Molina AA, Lopez PF. Simultaneous direct determination of amiloride and triamterene in urine using isopotential fluorometry. Anal Biochem 2001; 292: 59-68.